The recombinant protein is produced through E. coli-based cell-free expression systems, achieving ≥85% purity via SDS-PAGE . Key production details:
Storage: Tris-based buffer with 50% glycerol at -20°C (short-term) or -80°C (long-term)
Yield: Available in 0.02 mg to 5×0.1 mg quantities, with pricing from $1,690 to $12,440 USD
BAX/YccA Family: Potential involvement in apoptosis regulation or membrane stress responses
Streptococcal Pathogenesis: Conserved domains suggest possible roles in:
| Protein | Organism | Functional Clues |
|---|---|---|
| SpyM3_0260 | S. pyogenes M3 | Unknown |
| M6_Spy0327 | S. pyogenes M6 | Membrane organization |
| spyM18_0408 | S. pyogenes M18 | Stress response |
Immunoreactivity confirmed by western blot using infected swine sera (parallel validation method from )
Lot-to-lot consistency demonstrated through SDS-PAGE and functional assays (methodology adapted from )
Three-dimensional structure
Specific interacting partners
Role in streptococcal virulence
KEGG: spg:SpyM3_0260
SpyM3_0260 is an uncharacterized membrane protein derived from Streptococcus pyogenes serotype M3, a gram-positive bacterial pathogen. The protein is identified in the UniProt database with the accession number P0DA10. Currently, its physiological function remains largely unknown, making it a target for basic research investigations focused on bacterial membrane proteins . When working with this protein, researchers should consider its membrane-associated nature, which influences experimental design and handling protocols.
Multiple expression systems have been developed for the production of recombinant SpyM3_0260, each with specific advantages depending on your research requirements. Available systems include:
Bacterial (E. coli) expression - Product code CSB-EP317886SMV1
Yeast expression - Product code CSB-YP317886SMV1
Baculovirus-infected insect cells - Product code CSB-BP317886SMV1
The selection of an appropriate expression system should be guided by experimental objectives. For structural studies requiring post-translational modifications, eukaryotic systems (mammalian or insect cells) are preferable, while E. coli systems may be suitable for preliminary functional assays or when large protein quantities are needed.
Commercial preparations of recombinant SpyM3_0260 typically have a purity exceeding 85% as determined by SDS-PAGE analysis . The protein is generally supplied as a lyophilized powder, which requires reconstitution before experimental use. For optimal results, reconstitution should be performed in deionized sterile water to a concentration of 0.1-1.0 mg/mL. To enhance stability during storage, addition of 5-50% glycerol (final concentration) is recommended . Researchers should verify protein integrity via SDS-PAGE or Western blot prior to downstream applications.
The commercially available recombinant SpyM3_0260 is a partial-length protein, which presents both advantages and limitations for research applications . This partial structure may exclude certain domains or functional regions of the native protein, potentially affecting:
Protein folding and tertiary structure
Membrane insertion capabilities
Interaction profiles with potential binding partners
Enzymatic or signaling activities
When designing experiments with partial-length proteins, researchers must carefully consider which regions are present and absent. For comprehensive functional studies, it may be necessary to compare results using different constructs containing various domains. Structural prediction tools can help identify which functional motifs are preserved in the partial construct, guiding appropriate experimental design and interpretation of results.
As an uncharacterized membrane protein, determining the topology of SpyM3_0260 is crucial for understanding its function. Several complementary approaches are recommended:
Computational prediction: Tools such as TMHMM, MEMSAT, and Phobius can predict transmembrane domains and their orientation.
Protease protection assays: By expressing SpyM3_0260 in membrane vesicles and subjecting them to proteases, researchers can determine which regions are protected (intracellular/lumenal) versus exposed (extracellular).
Cysteine scanning mutagenesis: Introducing cysteine residues at different positions and assessing their accessibility to membrane-impermeable labeling reagents.
Fusion protein reporters: Creating fusions with reporters like GFP or alkaline phosphatase at different positions can reveal membrane topology based on reporter activity.
Cryo-electron microscopy: For high-resolution structural analysis, particularly if the protein can be purified with its native conformation intact .
Researchers should employ multiple approaches simultaneously, as each method has inherent limitations, particularly when working with uncharacterized proteins.
The Avi-tag biotinylated version of SpyM3_0260 (CSB-EP317886SMV1-B) offers significant advantages for protein-protein interaction investigations . This recombinant protein is biotinylated in vivo using AviTag-BirA technology, where BirA catalyzes the formation of an amide linkage between biotin and a specific lysine residue in the AviTag sequence.
Methodological applications include:
Pull-down assays: The exceptionally strong biotin-streptavidin interaction (Kd ≈ 10^-15 M) allows for highly efficient isolation of SpyM3_0260 along with its binding partners.
Surface plasmon resonance (SPR): Biotinylated SpyM3_0260 can be immobilized on streptavidin-coated sensor chips for real-time binding kinetics analysis.
Protein microarrays: The oriented immobilization ensures functional epitopes remain accessible, improving the sensitivity and specificity of array-based interaction studies.
Microscopy applications: When coupled with fluorescent streptavidin conjugates, biotinylated SpyM3_0260 can be used to visualize protein localization and interactions in cellular contexts.
This approach has advantages over traditional tagging methods as it allows for controlled, oriented immobilization that minimizes steric hindrance and preserves protein functionality .
For an uncharacterized membrane protein like SpyM3_0260, a systematic approach to functional characterization is essential:
Sequence-based prediction: Begin with bioinformatic analysis using tools like BLAST, Pfam, and InterPro to identify conserved domains, motifs, or homology to proteins of known function.
Structural prediction: Employ AI-based structure prediction tools (e.g., AlphaFold2) to generate structural models that may provide functional insights based on structural similarity to characterized proteins .
Expression profiling: Analyze under which conditions the native protein is expressed in S. pyogenes, which may provide clues about its physiological role.
Deletion/overexpression phenotyping: Generate knockout or overexpression strains in S. pyogenes to observe resulting phenotypes, particularly related to:
Membrane integrity
Antibiotic resistance
Stress response
Virulence in infection models
Protein interactome mapping: Identify binding partners through approaches such as:
Co-immunoprecipitation followed by mass spectrometry
Bacterial two-hybrid screening
Proximity labeling techniques
Lipid interaction studies: Assess binding preferences to different lipids using techniques like lipid overlay assays or liposome flotation assays, which may indicate functional membrane microdomains.
Data from these complementary approaches should be integrated to develop testable hypotheses about specific functions for targeted validation experiments.
Robust control design is particularly important when studying uncharacterized proteins:
Negative controls:
Empty vector or irrelevant protein expressed in the same system
Heat-denatured SpyM3_0260 to distinguish specific from non-specific effects
Scrambled peptide sequences for interaction studies
Positive controls:
Well-characterized membrane proteins from the same family (if known)
Known binding partners of related proteins
Established assays for similar membrane protein functions (transport, signaling, etc.)
System controls:
Expression of SpyM3_0260 in multiple systems to distinguish host-specific artifacts
Comparison of tagged versus untagged versions to assess tag interference
Concentration gradients to establish dose-dependent effects
Technical validation:
Multiple detection methods for key findings (e.g., different antibodies or detection systems)
Biological replicates from independent protein preparations
Orthogonal assays measuring the same phenomenon via different mechanisms
For each experiment, controls should be tailored to address specific potential artifacts or alternative explanations for observed phenomena .
Given the uncharacterized nature of SpyM3_0260, bioinformatic analyses provide crucial starting points for functional investigation:
Homology-based approaches:
BLAST searches against characterized proteins to identify functional homologs
Multiple sequence alignments to identify conserved residues indicative of functional sites
Phylogenetic analysis to understand evolutionary relationships and potential functional conservation
Structure-based prediction:
Protein threading to detect structural similarity to proteins of known function
Binding pocket identification and characterization
Molecular dynamics simulations to assess conformational flexibility and potential binding sites
Genomic context analysis:
Examination of neighboring genes in the S. pyogenes genome (operonic structure)
Comparative genomics across bacterial species to identify conserved genomic arrangements
Analysis of co-expression patterns with genes of known function
Network-based approaches:
Protein-protein interaction network predictions
Functional association networks from resources like STRING database
Gene ontology enrichment analysis of predicted interactors
Specialized membrane protein tools:
Transmembrane topology prediction (TMHMM, MEMSAT)
Signal peptide prediction (SignalP)
Lipid modification prediction (PrePS, GPS-Lipid)
Researchers should integrate results from multiple tools and approaches, looking for consensus predictions while remaining aware of the limitations of each method .
When working with uncharacterized proteins like SpyM3_0260, contradictory results are common due to limited prior knowledge. A systematic approach to resolving such contradictions includes:
Methodological assessment:
Evaluate whether different experimental systems (expression hosts, tags, buffers) might explain discrepancies
Consider whether partial versus full-length constructs produce different results
Assess whether membrane environment differences influence protein behavior
Condition-dependent functionality:
Test whether the protein exhibits different functions under different conditions (pH, temperature, ionic strength)
Consider allosteric regulation or conformational changes that might explain apparently contradictory functions
Investigate potential post-translational modifications affecting activity
Statistical rigor:
Increase sample sizes to improve statistical power
Apply appropriate statistical tests for the data type and distribution
Consider Bayesian approaches to integrate prior knowledge with new data
Collaborative verification:
Engage multiple laboratories to independently test key findings
Employ orthogonal techniques to verify results
Design decisive experiments specifically aimed at resolving contradictions
Literature comparison:
Examine whether related proteins show similar context-dependent behaviors
Look for precedents of multifunctional proteins with seemingly contradictory activities
Consider whether the contradictions reflect actual biological complexity rather than experimental artifacts
The scientific process often advances through the resolution of contradictory findings, particularly with novel proteins where initial characterization may reveal unexpected complexity .
Membrane proteins like SpyM3_0260 frequently present solubility and stability challenges. Researchers can implement several strategies to overcome these issues:
Optimizing solubilization conditions:
Screen different detergents (non-ionic, zwitterionic, ionic) at various concentrations
Test detergent mixtures which often perform better than single detergents
Evaluate detergent-lipid mixed micelles or nanodiscs for maintaining native-like environment
Consider amphipols or styrene maleic acid lipid particles (SMALPs) for detergent-free extraction
Buffer optimization:
Systematically vary pH, ionic strength, and salt composition
Include stabilizing additives such as glycerol (5-50%), specific lipids, or cholesterol
Test the addition of specific ligands or binding partners that may stabilize the protein
Construct engineering:
Remove flexible regions that may promote aggregation
Consider fusion partners known to enhance membrane protein solubility (e.g., SUMO, MBP)
Design truncations that preserve key domains while removing problematic regions
Introduce stability-enhancing mutations based on computational prediction
Storage considerations:
Determine optimal protein concentration to prevent concentration-dependent aggregation
Evaluate different storage temperatures (-80°C, -20°C, 4°C)
Test flash-freezing in liquid nitrogen versus slow freezing
Consider lyophilization with appropriate cryoprotectants
Quality control measures:
Implement size-exclusion chromatography to monitor oligomeric state and aggregation
Use circular dichroism to assess secondary structure integrity over time
Apply differential scanning fluorimetry to identify stabilizing conditions
Regularly check activity/binding to ensure functional integrity is maintained
Maintaining detailed records of conditions tested and outcomes observed is essential for developing optimal handling protocols for this challenging protein class .
Expression of membrane proteins like SpyM3_0260 can be challenging across different host systems. When troubleshooting expression issues:
E. coli expression optimization:
Test different strains specialized for membrane proteins (C41/C43, Lemo21)
Evaluate various promoters for controlled expression rates (T7, tac, araBAD)
Optimize induction conditions (temperature, inducer concentration, duration)
Co-express with chaperones to aid proper folding
Consider fusion to MBP, SUMO, or other solubility-enhancing tags
Yeast expression strategies:
Compare different yeast species (S. cerevisiae, P. pastoris)
Test constitutive versus inducible promoters
Optimize media composition and growth temperature
Evaluate different signal sequences for proper membrane targeting
Insect cell expression:
Compare different insect cell lines (Sf9, Sf21, High Five)
Optimize virus-to-cell ratio and expression time
Test various viral promoters for expression timing and level
Evaluate co-expression with chaperones or auxiliary proteins
Mammalian expression approaches:
Compare transient versus stable expression systems
Test different cell lines (HEK293, CHO, COS-7)
Optimize transfection methods and conditions
Consider inducible expression systems for toxic proteins
Cell-free expression systems:
When cellular expression fails, consider E. coli, wheat germ, or insect cell extract-based cell-free systems
Supplement with lipids or detergents to facilitate membrane protein folding
Optimize reaction components and conditions for membrane protein synthesis
Codon optimization:
Adapt the coding sequence to the codon bias of the expression host
Remove rare codons, especially those occurring in clusters
Optimize GC content and RNA secondary structures
Each expression system has distinct advantages for different types of membrane proteins, and systematic comparison is often necessary to identify the optimal system for SpyM3_0260 .